{
 "drug": "Lisdexamfetamine Dimesylate Capsule",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "07/14/2023",
 "dayN": 1138,
 "cat": "Psychiatry",
 "companies": [
  "Teva Pharmaceuticals USA, Inc.",
  "Hikma Pharmaceuticals USA, Inc.",
  "Amneal Pharmaceuticals",
  "Rhodes Pharmaceuticals L.P.",
  "Lannett Company, Inc.",
  "Takeda Pharmaceuticals USA Inc.",
  "Solco Healthcare US, LLC",
  "SpecGx LLC",
  "Apotex Corp.",
  "Mylan Pharmaceuticals Inc., a Viatris Company",
  "Alvogen",
  "Sun Pharmaceutical Industries, Inc.",
  "Elite Laboratories, Inc."
 ],
 "reasons": [
  "Shortage of an active ingredient",
  "Other",
  "Delay in shipping of the drug"
 ],
 "records": [
  {
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01)",
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0480-3564-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "status": "Current",
   "dosage_form": "Capsule"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0054-0370-25",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Available on allocation",
   "openfda": {
    "application_number": [
     "ANDA202827"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0054-0370",
     "0054-0660",
     "0054-0371",
     "0054-0372",
     "0054-0373",
     "0054-0374",
     "0054-0375"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"
    ],
    "spl_set_id": [
     "6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    ],
    "package_ndc": [
     "0054-0660-25",
     "0054-0370-25",
     "0054-0371-25",
     "0054-0372-25",
     "0054-0373-25",
     "0054-0374-25",
     "0054-0375-25"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "65162-024-09",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202830"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "65162-024",
     "65162-023",
     "65162-025",
     "65162-026",
     "65162-027",
     "65162-028"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850"
    ],
    "spl_id": [
     "ba9f3370-3096-4d8c-9571-e28faf54291f"
    ],
    "spl_set_id": [
     "c11cb3b6-3dff-477b-a249-b4c3118edc5f"
    ],
    "package_ndc": [
     "65162-023-09",
     "65162-024-09",
     "65162-025-09",
     "65162-026-09",
     "65162-027-09",
     "65162-028-09"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01)",
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0480-3570-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "status": "Current",
   "dosage_form": "Capsule"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "42858-164-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-827-0616",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA215330"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Rhodes Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "42858-164",
     "42858-161",
     "42858-162",
     "42858-163",
     "42858-165",
     "42858-166",
     "42858-167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "0002e227-1109-4ecc-a8c5-4b4f11fac3cc"
    ],
    "spl_set_id": [
     "d918b40d-a461-41bc-b6c0-83dc76c28e32"
    ],
    "package_ndc": [
     "42858-161-01",
     "42858-162-01",
     "42858-163-01",
     "42858-164-01",
     "42858-165-01",
     "42858-166-01",
     "42858-167-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/24/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)",
   "company_name": "Rhodes Pharmaceuticals L.P.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0527-4664-37",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215802"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "0527-4664",
     "0527-4661",
     "0527-4662",
     "0527-4663",
     "0527-4665",
     "0527-4666",
     "0527-4667"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "cb49954d-0f9d-4471-bc86-0c926473c00b"
    ],
    "spl_set_id": [
     "2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"
    ],
    "package_ndc": [
     "0527-4661-37",
     "0527-4662-37",
     "0527-4663-37",
     "0527-4664-37",
     "0527-4665-37",
     "0527-4666-37",
     "0527-4667-37"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "59417-104-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "877-TAKEDA-7 (1-877-825-3327)",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021977"
    ],
    "brand_name": [
     "VYVANSE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "59417-104",
     "59417-101",
     "59417-102",
     "59417-103",
     "59417-105",
     "59417-106",
     "59417-107",
     "59417-115",
     "59417-116",
     "59417-117",
     "59417-118",
     "59417-119",
     "59417-120"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854832",
     "854834",
     "854836",
     "854838",
     "854840",
     "854842",
     "854844",
     "854846",
     "854848",
     "854850",
     "854852",
     "1593856",
     "1593858",
     "1871456",
     "1871459",
     "1871460",
     "1871461",
     "1871462",
     "1871463",
     "1871464",
     "1871465",
     "1871466",
     "1871467",
     "1871468",
     "1871469"
    ],
    "spl_id": [
     "81d087b6-4cb4-466a-9693-679edeb062e2"
    ],
    "spl_set_id": [
     "704e4378-ca83-445c-8b45-3cfa51c1ecad"
    ],
    "package_ndc": [
     "59417-101-10",
     "59417-102-10",
     "59417-103-10",
     "59417-104-10",
     "59417-105-10",
     "59417-106-10",
     "59417-107-10",
     "59417-115-01",
     "59417-116-01",
     "59417-117-01",
     "59417-118-01",
     "59417-119-01",
     "59417-120-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Vyvanse, Capsule, 40 mg (NDC 59417-104-10)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "43547-606-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-931-9829",
   "availability": "Limited Availability",
   "related_info": "On allocation",
   "openfda": {
    "application_number": [
     "ANDA216266"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE CAPSULES"
    ],
    "manufacturer_name": [
     "Solco Healthcare US,LLC"
    ],
    "product_ndc": [
     "43547-606",
     "43547-602",
     "43547-603",
     "43547-604",
     "43547-605",
     "43547-607",
     "43547-608"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "d6435613-e052-4b4f-8bf7-4acb7458d8df"
    ],
    "spl_set_id": [
     "68b10d9f-ca3e-493d-a309-45f1d7e08061"
    ],
    "package_ndc": [
     "43547-602-10",
     "43547-603-10",
     "43547-604-10",
     "43547-605-10",
     "43547-606-10",
     "43547-607-10",
     "43547-608-10"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10)",
   "company_name": "Solco Healthcare US, LLC",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0406-5112-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-325-8888",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211840"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "SpecGx LLC"
    ],
    "product_ndc": [
     "0406-5112",
     "0406-5111",
     "0406-5113",
     "0406-5114",
     "0406-5115",
     "0406-5116",
     "0406-5117"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "b4be564a-404d-4ca1-bac0-ec9cf40fef93"
    ],
    "spl_set_id": [
     "806a1c15-0842-4787-b2ad-09a21fd96b37"
    ],
    "package_ndc": [
     "0406-5111-01",
     "0406-5112-01",
     "0406-5113-01",
     "0406-5114-01",
     "0406-5115-01",
     "0406-5116-01",
     "0406-5117-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)",
   "company_name": "SpecGx LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2023",
   "package_ndc": "60505-4739-1",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-706-5575",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA216944"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-4739",
     "60505-4740",
     "60505-4741",
     "60505-4742",
     "60505-4743",
     "60505-4744",
     "60505-4745"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2eec36cd-6063-fea0-d6dd-b7a5c8df186b"
    ],
    "spl_set_id": [
     "ecad4442-a644-18e3-6ff2-fdbac45eec47"
    ],
    "package_ndc": [
     "60505-4739-1",
     "60505-4740-1",
     "60505-4741-1",
     "60505-4742-1",
     "60505-4743-1",
     "60505-4744-1",
     "60505-4745-1"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1)",
   "company_name": "Apotex Corp.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "43547-604-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-931-9829",
   "availability": "Limited Availability",
   "related_info": "On allocation",
   "openfda": {
    "application_number": [
     "ANDA216266"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE CAPSULES"
    ],
    "manufacturer_name": [
     "Solco Healthcare US,LLC"
    ],
    "product_ndc": [
     "43547-604",
     "43547-602",
     "43547-603",
     "43547-605",
     "43547-606",
     "43547-607",
     "43547-608"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "d6435613-e052-4b4f-8bf7-4acb7458d8df"
    ],
    "spl_set_id": [
     "68b10d9f-ca3e-493d-a309-45f1d7e08061"
    ],
    "package_ndc": [
     "43547-602-10",
     "43547-603-10",
     "43547-604-10",
     "43547-605-10",
     "43547-606-10",
     "43547-607-10",
     "43547-608-10"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)",
   "company_name": "Solco Healthcare US, LLC",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0378-6859-77",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202835"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-6859",
     "0378-6854",
     "0378-6855",
     "0378-6856",
     "0378-6857",
     "0378-6858",
     "0378-6860"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "6e77cd71-95ae-4fa8-830b-ab62b714e4b9"
    ],
    "spl_set_id": [
     "efbde0f6-b848-4664-b741-c6c630e66108"
    ],
    "package_ndc": [
     "0378-6854-77",
     "0378-6855-77",
     "0378-6856-77",
     "0378-6857-77",
     "0378-6858-77",
     "0378-6859-77",
     "0378-6860-77"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "47781-564-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214547"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Alvogen Inc."
    ],
    "product_ndc": [
     "47781-564",
     "47781-562",
     "47781-563",
     "47781-565",
     "47781-566",
     "47781-567",
     "47781-568"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "db02ec6b-f17f-ab22-b671-e1ddb90e017c"
    ],
    "spl_set_id": [
     "7f2dd6ee-3363-c87c-9693-ed838942556c"
    ],
    "package_ndc": [
     "47781-562-01",
     "47781-563-01",
     "47781-564-01",
     "47781-565-01",
     "47781-566-01",
     "47781-567-01",
     "47781-568-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01)",
   "company_name": "Alvogen",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "65162-027-09",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202830"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "65162-027",
     "65162-023",
     "65162-024",
     "65162-025",
     "65162-026",
     "65162-028"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850"
    ],
    "spl_id": [
     "ba9f3370-3096-4d8c-9571-e28faf54291f"
    ],
    "spl_set_id": [
     "c11cb3b6-3dff-477b-a249-b4c3118edc5f"
    ],
    "package_ndc": [
     "65162-023-09",
     "65162-024-09",
     "65162-025-09",
     "65162-026-09",
     "65162-027-09",
     "65162-028-09"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "59417-103-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "877-TAKEDA-7 (1-877-825-3327)",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021977"
    ],
    "brand_name": [
     "VYVANSE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "59417-103",
     "59417-101",
     "59417-102",
     "59417-104",
     "59417-105",
     "59417-106",
     "59417-107",
     "59417-115",
     "59417-116",
     "59417-117",
     "59417-118",
     "59417-119",
     "59417-120"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854832",
     "854834",
     "854836",
     "854838",
     "854840",
     "854842",
     "854844",
     "854846",
     "854848",
     "854850",
     "854852",
     "1593856",
     "1593858",
     "1871456",
     "1871459",
     "1871460",
     "1871461",
     "1871462",
     "1871463",
     "1871464",
     "1871465",
     "1871466",
     "1871467",
     "1871468",
     "1871469"
    ],
    "spl_id": [
     "81d087b6-4cb4-466a-9693-679edeb062e2"
    ],
    "spl_set_id": [
     "704e4378-ca83-445c-8b45-3cfa51c1ecad"
    ],
    "package_ndc": [
     "59417-101-10",
     "59417-102-10",
     "59417-103-10",
     "59417-104-10",
     "59417-105-10",
     "59417-106-10",
     "59417-107-10",
     "59417-115-01",
     "59417-116-01",
     "59417-117-01",
     "59417-118-01",
     "59417-119-01",
     "59417-120-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Vyvanse, Capsule, 30 mg (NDC 59417-103-10)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "42858-163-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-827-0616",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA215330"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Rhodes Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "42858-163",
     "42858-161",
     "42858-162",
     "42858-164",
     "42858-165",
     "42858-166",
     "42858-167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "0002e227-1109-4ecc-a8c5-4b4f11fac3cc"
    ],
    "spl_set_id": [
     "d918b40d-a461-41bc-b6c0-83dc76c28e32"
    ],
    "package_ndc": [
     "42858-161-01",
     "42858-162-01",
     "42858-163-01",
     "42858-164-01",
     "42858-165-01",
     "42858-166-01",
     "42858-167-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/24/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01)",
   "company_name": "Rhodes Pharmaceuticals L.P.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0378-6858-77",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202835"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-6858",
     "0378-6854",
     "0378-6855",
     "0378-6856",
     "0378-6857",
     "0378-6859",
     "0378-6860"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "6e77cd71-95ae-4fa8-830b-ab62b714e4b9"
    ],
    "spl_set_id": [
     "efbde0f6-b848-4664-b741-c6c630e66108"
    ],
    "package_ndc": [
     "0378-6854-77",
     "0378-6855-77",
     "0378-6856-77",
     "0378-6857-77",
     "0378-6858-77",
     "0378-6859-77",
     "0378-6860-77"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "47781-562-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214547"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Alvogen Inc."
    ],
    "product_ndc": [
     "47781-562",
     "47781-563",
     "47781-564",
     "47781-565",
     "47781-566",
     "47781-567",
     "47781-568"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "db02ec6b-f17f-ab22-b671-e1ddb90e017c"
    ],
    "spl_set_id": [
     "7f2dd6ee-3363-c87c-9693-ed838942556c"
    ],
    "package_ndc": [
     "47781-562-01",
     "47781-563-01",
     "47781-564-01",
     "47781-565-01",
     "47781-566-01",
     "47781-567-01",
     "47781-568-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)",
   "company_name": "Alvogen",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "57664-048-88",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-818-4555",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA214484"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Sun Pharmaceutical Industries, Inc."
    ],
    "product_ndc": [
     "57664-048",
     "57664-047",
     "57664-046",
     "57664-049",
     "57664-050",
     "57664-051",
     "57664-052",
     "57664-083",
     "57664-084",
     "57664-085",
     "57664-086",
     "57664-087",
     "57664-088"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856",
     "1871456",
     "1871460",
     "1871462",
     "1871464",
     "1871466",
     "1871468"
    ],
    "spl_id": [
     "560b4c9e-9cce-4717-e063-6294a90a58c9"
    ],
    "spl_set_id": [
     "da3148af-f9b6-4725-adae-3595b4c7dc4b"
    ],
    "package_ndc": [
     "57664-047-88",
     "57664-046-88",
     "57664-048-88",
     "57664-049-88",
     "57664-050-88",
     "57664-051-88",
     "57664-052-88",
     "57664-083-88",
     "57664-084-88",
     "57664-085-88",
     "57664-086-88",
     "57664-087-88",
     "57664-088-88"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-048-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "47781-565-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214547"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Alvogen Inc."
    ],
    "product_ndc": [
     "47781-565",
     "47781-562",
     "47781-563",
     "47781-564",
     "47781-566",
     "47781-567",
     "47781-568"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "db02ec6b-f17f-ab22-b671-e1ddb90e017c"
    ],
    "spl_set_id": [
     "7f2dd6ee-3363-c87c-9693-ed838942556c"
    ],
    "package_ndc": [
     "47781-562-01",
     "47781-563-01",
     "47781-564-01",
     "47781-565-01",
     "47781-566-01",
     "47781-567-01",
     "47781-568-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01)",
   "company_name": "Alvogen",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "43547-602-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-931-9829",
   "availability": "Limited Availability",
   "related_info": "On allocation",
   "openfda": {
    "application_number": [
     "ANDA216266"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE CAPSULES"
    ],
    "manufacturer_name": [
     "Solco Healthcare US,LLC"
    ],
    "product_ndc": [
     "43547-602",
     "43547-603",
     "43547-604",
     "43547-605",
     "43547-606",
     "43547-607",
     "43547-608"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "d6435613-e052-4b4f-8bf7-4acb7458d8df"
    ],
    "spl_set_id": [
     "68b10d9f-ca3e-493d-a309-45f1d7e08061"
    ],
    "package_ndc": [
     "43547-602-10",
     "43547-603-10",
     "43547-604-10",
     "43547-605-10",
     "43547-606-10",
     "43547-607-10",
     "43547-608-10"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10)",
   "company_name": "Solco Healthcare US, LLC",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0054-0371-25",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Available on allocation",
   "openfda": {
    "application_number": [
     "ANDA202827"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0054-0371",
     "0054-0660",
     "0054-0370",
     "0054-0372",
     "0054-0373",
     "0054-0374",
     "0054-0375"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"
    ],
    "spl_set_id": [
     "6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    ],
    "package_ndc": [
     "0054-0660-25",
     "0054-0370-25",
     "0054-0371-25",
     "0054-0372-25",
     "0054-0373-25",
     "0054-0374-25",
     "0054-0375-25"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "65162-025-09",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202830"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "65162-025",
     "65162-023",
     "65162-024",
     "65162-026",
     "65162-027",
     "65162-028"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850"
    ],
    "spl_id": [
     "ba9f3370-3096-4d8c-9571-e28faf54291f"
    ],
    "spl_set_id": [
     "c11cb3b6-3dff-477b-a249-b4c3118edc5f"
    ],
    "package_ndc": [
     "65162-023-09",
     "65162-024-09",
     "65162-025-09",
     "65162-026-09",
     "65162-027-09",
     "65162-028-09"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0054-0660-25",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Available on allocation",
   "openfda": {
    "application_number": [
     "ANDA202827"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0054-0660",
     "0054-0370",
     "0054-0371",
     "0054-0372",
     "0054-0373",
     "0054-0374",
     "0054-0375"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"
    ],
    "spl_set_id": [
     "6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    ],
    "package_ndc": [
     "0054-0660-25",
     "0054-0370-25",
     "0054-0371-25",
     "0054-0372-25",
     "0054-0373-25",
     "0054-0374-25",
     "0054-0375-25"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "05/12/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "42858-161-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-827-0616",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215330"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Rhodes Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "42858-161",
     "42858-162",
     "42858-163",
     "42858-164",
     "42858-165",
     "42858-166",
     "42858-167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "0002e227-1109-4ecc-a8c5-4b4f11fac3cc"
    ],
    "spl_set_id": [
     "d918b40d-a461-41bc-b6c0-83dc76c28e32"
    ],
    "package_ndc": [
     "42858-161-01",
     "42858-162-01",
     "42858-163-01",
     "42858-164-01",
     "42858-165-01",
     "42858-166-01",
     "42858-167-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/24/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)",
   "company_name": "Rhodes Pharmaceuticals L.P.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "59417-106-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "877-TAKEDA-7 (1-877-825-3327)",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021977"
    ],
    "brand_name": [
     "VYVANSE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "59417-106",
     "59417-101",
     "59417-102",
     "59417-103",
     "59417-104",
     "59417-105",
     "59417-107",
     "59417-115",
     "59417-116",
     "59417-117",
     "59417-118",
     "59417-119",
     "59417-120"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854832",
     "854834",
     "854836",
     "854838",
     "854840",
     "854842",
     "854844",
     "854846",
     "854848",
     "854850",
     "854852",
     "1593856",
     "1593858",
     "1871456",
     "1871459",
     "1871460",
     "1871461",
     "1871462",
     "1871463",
     "1871464",
     "1871465",
     "1871466",
     "1871467",
     "1871468",
     "1871469"
    ],
    "spl_id": [
     "81d087b6-4cb4-466a-9693-679edeb062e2"
    ],
    "spl_set_id": [
     "704e4378-ca83-445c-8b45-3cfa51c1ecad"
    ],
    "package_ndc": [
     "59417-101-10",
     "59417-102-10",
     "59417-103-10",
     "59417-104-10",
     "59417-105-10",
     "59417-106-10",
     "59417-107-10",
     "59417-115-01",
     "59417-116-01",
     "59417-117-01",
     "59417-118-01",
     "59417-119-01",
     "59417-120-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Vyvanse, Capsule, 60 mg (NDC 59417-106-10)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "57664-052-88",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-818-4555",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA214484"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Sun Pharmaceutical Industries, Inc."
    ],
    "product_ndc": [
     "57664-052",
     "57664-047",
     "57664-046",
     "57664-048",
     "57664-049",
     "57664-050",
     "57664-051",
     "57664-083",
     "57664-084",
     "57664-085",
     "57664-086",
     "57664-087",
     "57664-088"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856",
     "1871456",
     "1871460",
     "1871462",
     "1871464",
     "1871466",
     "1871468"
    ],
    "spl_id": [
     "560b4c9e-9cce-4717-e063-6294a90a58c9"
    ],
    "spl_set_id": [
     "da3148af-f9b6-4725-adae-3595b4c7dc4b"
    ],
    "package_ndc": [
     "57664-047-88",
     "57664-046-88",
     "57664-048-88",
     "57664-049-88",
     "57664-050-88",
     "57664-051-88",
     "57664-052-88",
     "57664-083-88",
     "57664-084-88",
     "57664-085-88",
     "57664-086-88",
     "57664-087-88",
     "57664-088-88"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "42858-165-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-827-0616",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA215330"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Rhodes Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "42858-165",
     "42858-161",
     "42858-162",
     "42858-163",
     "42858-164",
     "42858-166",
     "42858-167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "0002e227-1109-4ecc-a8c5-4b4f11fac3cc"
    ],
    "spl_set_id": [
     "d918b40d-a461-41bc-b6c0-83dc76c28e32"
    ],
    "package_ndc": [
     "42858-161-01",
     "42858-162-01",
     "42858-163-01",
     "42858-164-01",
     "42858-165-01",
     "42858-166-01",
     "42858-167-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/24/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01)",
   "company_name": "Rhodes Pharmaceuticals L.P.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0527-4662-37",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215802"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "0527-4662",
     "0527-4661",
     "0527-4663",
     "0527-4664",
     "0527-4665",
     "0527-4666",
     "0527-4667"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "cb49954d-0f9d-4471-bc86-0c926473c00b"
    ],
    "spl_set_id": [
     "2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"
    ],
    "package_ndc": [
     "0527-4661-37",
     "0527-4662-37",
     "0527-4663-37",
     "0527-4664-37",
     "0527-4665-37",
     "0527-4666-37",
     "0527-4667-37"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0378-6857-77",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202835"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-6857",
     "0378-6854",
     "0378-6855",
     "0378-6856",
     "0378-6858",
     "0378-6859",
     "0378-6860"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "6e77cd71-95ae-4fa8-830b-ab62b714e4b9"
    ],
    "spl_set_id": [
     "efbde0f6-b848-4664-b741-c6c630e66108"
    ],
    "package_ndc": [
     "0378-6854-77",
     "0378-6855-77",
     "0378-6856-77",
     "0378-6857-77",
     "0378-6858-77",
     "0378-6859-77",
     "0378-6860-77"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "64850-556-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-852-6657",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA218604"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Elite Laboratories, Inc."
    ],
    "product_ndc": [
     "64850-556",
     "64850-550",
     "64850-551",
     "64850-552",
     "64850-553",
     "64850-554",
     "64850-555"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2d33f701-8067-4a48-98cc-4e7dacaf3cc4"
    ],
    "spl_set_id": [
     "0e024b69-567c-4b40-9c3e-a2daec34256c"
    ],
    "package_ndc": [
     "64850-550-01",
     "64850-551-01",
     "64850-552-01",
     "64850-553-01",
     "64850-554-01",
     "64850-555-01",
     "64850-556-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01)",
   "company_name": "Elite Laboratories, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "47781-566-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214547"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Alvogen Inc."
    ],
    "product_ndc": [
     "47781-566",
     "47781-562",
     "47781-563",
     "47781-564",
     "47781-565",
     "47781-567",
     "47781-568"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "db02ec6b-f17f-ab22-b671-e1ddb90e017c"
    ],
    "spl_set_id": [
     "7f2dd6ee-3363-c87c-9693-ed838942556c"
    ],
    "package_ndc": [
     "47781-562-01",
     "47781-563-01",
     "47781-564-01",
     "47781-565-01",
     "47781-566-01",
     "47781-567-01",
     "47781-568-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01)",
   "company_name": "Alvogen",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0406-5113-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-325-8888",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211840"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "SpecGx LLC"
    ],
    "product_ndc": [
     "0406-5113",
     "0406-5111",
     "0406-5112",
     "0406-5114",
     "0406-5115",
     "0406-5116",
     "0406-5117"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "b4be564a-404d-4ca1-bac0-ec9cf40fef93"
    ],
    "spl_set_id": [
     "806a1c15-0842-4787-b2ad-09a21fd96b37"
    ],
    "package_ndc": [
     "0406-5111-01",
     "0406-5112-01",
     "0406-5113-01",
     "0406-5114-01",
     "0406-5115-01",
     "0406-5116-01",
     "0406-5117-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01)",
   "company_name": "SpecGx LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "47781-568-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214547"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Alvogen Inc."
    ],
    "product_ndc": [
     "47781-568",
     "47781-562",
     "47781-563",
     "47781-564",
     "47781-565",
     "47781-566",
     "47781-567"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "db02ec6b-f17f-ab22-b671-e1ddb90e017c"
    ],
    "spl_set_id": [
     "7f2dd6ee-3363-c87c-9693-ed838942556c"
    ],
    "package_ndc": [
     "47781-562-01",
     "47781-563-01",
     "47781-564-01",
     "47781-565-01",
     "47781-566-01",
     "47781-567-01",
     "47781-568-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01)",
   "company_name": "Alvogen",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/01/2023",
   "package_ndc": "60505-4740-1",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-706-5575",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: 10/20/26",
   "openfda": {
    "application_number": [
     "ANDA216944"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-4740",
     "60505-4739",
     "60505-4741",
     "60505-4742",
     "60505-4743",
     "60505-4744",
     "60505-4745"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2eec36cd-6063-fea0-d6dd-b7a5c8df186b"
    ],
    "spl_set_id": [
     "ecad4442-a644-18e3-6ff2-fdbac45eec47"
    ],
    "package_ndc": [
     "60505-4739-1",
     "60505-4740-1",
     "60505-4741-1",
     "60505-4742-1",
     "60505-4743-1",
     "60505-4744-1",
     "60505-4745-1"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1)",
   "company_name": "Apotex Corp.",
   "shortage_reason": "Delay in shipping of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2023",
   "package_ndc": "60505-4745-1",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-706-5575",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA216944"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-4745",
     "60505-4739",
     "60505-4740",
     "60505-4741",
     "60505-4742",
     "60505-4743",
     "60505-4744"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2eec36cd-6063-fea0-d6dd-b7a5c8df186b"
    ],
    "spl_set_id": [
     "ecad4442-a644-18e3-6ff2-fdbac45eec47"
    ],
    "package_ndc": [
     "60505-4739-1",
     "60505-4740-1",
     "60505-4741-1",
     "60505-4742-1",
     "60505-4743-1",
     "60505-4744-1",
     "60505-4745-1"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1)",
   "company_name": "Apotex Corp.",
   "status": "Current"
  },
  {
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)",
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0480-3566-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "status": "Current",
   "dosage_form": "Capsule"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0406-5111-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-325-8888",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211840"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "SpecGx LLC"
    ],
    "product_ndc": [
     "0406-5111",
     "0406-5112",
     "0406-5113",
     "0406-5114",
     "0406-5115",
     "0406-5116",
     "0406-5117"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "b4be564a-404d-4ca1-bac0-ec9cf40fef93"
    ],
    "spl_set_id": [
     "806a1c15-0842-4787-b2ad-09a21fd96b37"
    ],
    "package_ndc": [
     "0406-5111-01",
     "0406-5112-01",
     "0406-5113-01",
     "0406-5114-01",
     "0406-5115-01",
     "0406-5116-01",
     "0406-5117-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01)",
   "company_name": "SpecGx LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "65162-026-09",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202830"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "65162-026",
     "65162-023",
     "65162-024",
     "65162-025",
     "65162-027",
     "65162-028"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850"
    ],
    "spl_id": [
     "ba9f3370-3096-4d8c-9571-e28faf54291f"
    ],
    "spl_set_id": [
     "c11cb3b6-3dff-477b-a249-b4c3118edc5f"
    ],
    "package_ndc": [
     "65162-023-09",
     "65162-024-09",
     "65162-025-09",
     "65162-026-09",
     "65162-027-09",
     "65162-028-09"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0378-6860-77",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202835"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-6860",
     "0378-6854",
     "0378-6855",
     "0378-6856",
     "0378-6857",
     "0378-6858",
     "0378-6859"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "6e77cd71-95ae-4fa8-830b-ab62b714e4b9"
    ],
    "spl_set_id": [
     "efbde0f6-b848-4664-b741-c6c630e66108"
    ],
    "package_ndc": [
     "0378-6854-77",
     "0378-6855-77",
     "0378-6856-77",
     "0378-6857-77",
     "0378-6858-77",
     "0378-6859-77",
     "0378-6860-77"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "59417-107-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "877-TAKEDA-7 (1-877-825-3327)",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021977"
    ],
    "brand_name": [
     "VYVANSE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "59417-107",
     "59417-101",
     "59417-102",
     "59417-103",
     "59417-104",
     "59417-105",
     "59417-106",
     "59417-115",
     "59417-116",
     "59417-117",
     "59417-118",
     "59417-119",
     "59417-120"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854832",
     "854834",
     "854836",
     "854838",
     "854840",
     "854842",
     "854844",
     "854846",
     "854848",
     "854850",
     "854852",
     "1593856",
     "1593858",
     "1871456",
     "1871459",
     "1871460",
     "1871461",
     "1871462",
     "1871463",
     "1871464",
     "1871465",
     "1871466",
     "1871467",
     "1871468",
     "1871469"
    ],
    "spl_id": [
     "81d087b6-4cb4-466a-9693-679edeb062e2"
    ],
    "spl_set_id": [
     "704e4378-ca83-445c-8b45-3cfa51c1ecad"
    ],
    "package_ndc": [
     "59417-101-10",
     "59417-102-10",
     "59417-103-10",
     "59417-104-10",
     "59417-105-10",
     "59417-106-10",
     "59417-107-10",
     "59417-115-01",
     "59417-116-01",
     "59417-117-01",
     "59417-118-01",
     "59417-119-01",
     "59417-120-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Vyvanse, Capsule, 70 mg (NDC 59417-107-10)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0527-4661-37",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215802"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "0527-4661",
     "0527-4662",
     "0527-4663",
     "0527-4664",
     "0527-4665",
     "0527-4666",
     "0527-4667"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "cb49954d-0f9d-4471-bc86-0c926473c00b"
    ],
    "spl_set_id": [
     "2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"
    ],
    "package_ndc": [
     "0527-4661-37",
     "0527-4662-37",
     "0527-4663-37",
     "0527-4664-37",
     "0527-4665-37",
     "0527-4666-37",
     "0527-4667-37"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "65162-028-09",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202830"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "65162-028",
     "65162-023",
     "65162-024",
     "65162-025",
     "65162-026",
     "65162-027"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850"
    ],
    "spl_id": [
     "ba9f3370-3096-4d8c-9571-e28faf54291f"
    ],
    "spl_set_id": [
     "c11cb3b6-3dff-477b-a249-b4c3118edc5f"
    ],
    "package_ndc": [
     "65162-023-09",
     "65162-024-09",
     "65162-025-09",
     "65162-026-09",
     "65162-027-09",
     "65162-028-09"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "01/11/2024",
   "package_ndc": "42858-167-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-827-0616",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA215330"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Rhodes Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "42858-167",
     "42858-161",
     "42858-162",
     "42858-163",
     "42858-164",
     "42858-165",
     "42858-166"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "0002e227-1109-4ecc-a8c5-4b4f11fac3cc"
    ],
    "spl_set_id": [
     "d918b40d-a461-41bc-b6c0-83dc76c28e32"
    ],
    "package_ndc": [
     "42858-161-01",
     "42858-162-01",
     "42858-163-01",
     "42858-164-01",
     "42858-165-01",
     "42858-166-01",
     "42858-167-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/24/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01)",
   "company_name": "Rhodes Pharmaceuticals L.P.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "64850-555-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-852-6657",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA218604"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Elite Laboratories, Inc."
    ],
    "product_ndc": [
     "64850-555",
     "64850-550",
     "64850-551",
     "64850-552",
     "64850-553",
     "64850-554",
     "64850-556"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2d33f701-8067-4a48-98cc-4e7dacaf3cc4"
    ],
    "spl_set_id": [
     "0e024b69-567c-4b40-9c3e-a2daec34256c"
    ],
    "package_ndc": [
     "64850-550-01",
     "64850-551-01",
     "64850-552-01",
     "64850-553-01",
     "64850-554-01",
     "64850-555-01",
     "64850-556-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01)",
   "company_name": "Elite Laboratories, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0406-5114-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-325-8888",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211840"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "SpecGx LLC"
    ],
    "product_ndc": [
     "0406-5114",
     "0406-5111",
     "0406-5112",
     "0406-5113",
     "0406-5115",
     "0406-5116",
     "0406-5117"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "b4be564a-404d-4ca1-bac0-ec9cf40fef93"
    ],
    "spl_set_id": [
     "806a1c15-0842-4787-b2ad-09a21fd96b37"
    ],
    "package_ndc": [
     "0406-5111-01",
     "0406-5112-01",
     "0406-5113-01",
     "0406-5114-01",
     "0406-5115-01",
     "0406-5116-01",
     "0406-5117-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01)",
   "company_name": "SpecGx LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2023",
   "package_ndc": "60505-4741-1",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-706-5575",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA216944"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-4741",
     "60505-4739",
     "60505-4740",
     "60505-4742",
     "60505-4743",
     "60505-4744",
     "60505-4745"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2eec36cd-6063-fea0-d6dd-b7a5c8df186b"
    ],
    "spl_set_id": [
     "ecad4442-a644-18e3-6ff2-fdbac45eec47"
    ],
    "package_ndc": [
     "60505-4739-1",
     "60505-4740-1",
     "60505-4741-1",
     "60505-4742-1",
     "60505-4743-1",
     "60505-4744-1",
     "60505-4745-1"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)",
   "company_name": "Apotex Corp.",
   "status": "Current"
  },
  {
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01)",
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0480-3567-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "status": "Current",
   "dosage_form": "Capsule"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0054-0372-25",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Available on allocation",
   "openfda": {
    "application_number": [
     "ANDA202827"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0054-0372",
     "0054-0660",
     "0054-0370",
     "0054-0371",
     "0054-0373",
     "0054-0374",
     "0054-0375"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"
    ],
    "spl_set_id": [
     "6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    ],
    "package_ndc": [
     "0054-0660-25",
     "0054-0370-25",
     "0054-0371-25",
     "0054-0372-25",
     "0054-0373-25",
     "0054-0374-25",
     "0054-0375-25"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0378-6854-77",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202835"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-6854",
     "0378-6855",
     "0378-6856",
     "0378-6857",
     "0378-6858",
     "0378-6859",
     "0378-6860"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "6e77cd71-95ae-4fa8-830b-ab62b714e4b9"
    ],
    "spl_set_id": [
     "efbde0f6-b848-4664-b741-c6c630e66108"
    ],
    "package_ndc": [
     "0378-6854-77",
     "0378-6855-77",
     "0378-6856-77",
     "0378-6857-77",
     "0378-6858-77",
     "0378-6859-77",
     "0378-6860-77"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "59417-102-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "877-TAKEDA-7 (1-877-825-3327)",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021977"
    ],
    "brand_name": [
     "VYVANSE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "59417-102",
     "59417-101",
     "59417-103",
     "59417-104",
     "59417-105",
     "59417-106",
     "59417-107",
     "59417-115",
     "59417-116",
     "59417-117",
     "59417-118",
     "59417-119",
     "59417-120"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854832",
     "854834",
     "854836",
     "854838",
     "854840",
     "854842",
     "854844",
     "854846",
     "854848",
     "854850",
     "854852",
     "1593856",
     "1593858",
     "1871456",
     "1871459",
     "1871460",
     "1871461",
     "1871462",
     "1871463",
     "1871464",
     "1871465",
     "1871466",
     "1871467",
     "1871468",
     "1871469"
    ],
    "spl_id": [
     "81d087b6-4cb4-466a-9693-679edeb062e2"
    ],
    "spl_set_id": [
     "704e4378-ca83-445c-8b45-3cfa51c1ecad"
    ],
    "package_ndc": [
     "59417-101-10",
     "59417-102-10",
     "59417-103-10",
     "59417-104-10",
     "59417-105-10",
     "59417-106-10",
     "59417-107-10",
     "59417-115-01",
     "59417-116-01",
     "59417-117-01",
     "59417-118-01",
     "59417-119-01",
     "59417-120-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Vyvanse, Capsule, 20 mg (NDC 59417-102-10)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "64850-551-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-852-6657",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA218604"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Elite Laboratories, Inc."
    ],
    "product_ndc": [
     "64850-551",
     "64850-550",
     "64850-552",
     "64850-553",
     "64850-554",
     "64850-555",
     "64850-556"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2d33f701-8067-4a48-98cc-4e7dacaf3cc4"
    ],
    "spl_set_id": [
     "0e024b69-567c-4b40-9c3e-a2daec34256c"
    ],
    "package_ndc": [
     "64850-550-01",
     "64850-551-01",
     "64850-552-01",
     "64850-553-01",
     "64850-554-01",
     "64850-555-01",
     "64850-556-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01)",
   "company_name": "Elite Laboratories, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "43547-603-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-931-9829",
   "availability": "Limited Availability",
   "related_info": "On allocation",
   "openfda": {
    "application_number": [
     "ANDA216266"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE CAPSULES"
    ],
    "manufacturer_name": [
     "Solco Healthcare US,LLC"
    ],
    "product_ndc": [
     "43547-603",
     "43547-602",
     "43547-604",
     "43547-605",
     "43547-606",
     "43547-607",
     "43547-608"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "d6435613-e052-4b4f-8bf7-4acb7458d8df"
    ],
    "spl_set_id": [
     "68b10d9f-ca3e-493d-a309-45f1d7e08061"
    ],
    "package_ndc": [
     "43547-602-10",
     "43547-603-10",
     "43547-604-10",
     "43547-605-10",
     "43547-606-10",
     "43547-607-10",
     "43547-608-10"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10)",
   "company_name": "Solco Healthcare US, LLC",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "57664-048-88",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-818-4555",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA214484"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Sun Pharmaceutical Industries, Inc."
    ],
    "product_ndc": [
     "57664-048",
     "57664-047",
     "57664-046",
     "57664-049",
     "57664-050",
     "57664-051",
     "57664-052",
     "57664-083",
     "57664-084",
     "57664-085",
     "57664-086",
     "57664-087",
     "57664-088"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856",
     "1871456",
     "1871460",
     "1871462",
     "1871464",
     "1871466",
     "1871468"
    ],
    "spl_id": [
     "560b4c9e-9cce-4717-e063-6294a90a58c9"
    ],
    "spl_set_id": [
     "da3148af-f9b6-4725-adae-3595b4c7dc4b"
    ],
    "package_ndc": [
     "57664-047-88",
     "57664-046-88",
     "57664-048-88",
     "57664-049-88",
     "57664-050-88",
     "57664-051-88",
     "57664-052-88",
     "57664-083-88",
     "57664-084-88",
     "57664-085-88",
     "57664-086-88",
     "57664-087-88",
     "57664-088-88"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-048-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "47781-563-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214547"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Alvogen Inc."
    ],
    "product_ndc": [
     "47781-563",
     "47781-562",
     "47781-564",
     "47781-565",
     "47781-566",
     "47781-567",
     "47781-568"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "db02ec6b-f17f-ab22-b671-e1ddb90e017c"
    ],
    "spl_set_id": [
     "7f2dd6ee-3363-c87c-9693-ed838942556c"
    ],
    "package_ndc": [
     "47781-562-01",
     "47781-563-01",
     "47781-564-01",
     "47781-565-01",
     "47781-566-01",
     "47781-567-01",
     "47781-568-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01)",
   "company_name": "Alvogen",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "57664-046-88",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-818-4555",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA214484"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Sun Pharmaceutical Industries, Inc."
    ],
    "product_ndc": [
     "57664-046",
     "57664-047",
     "57664-048",
     "57664-049",
     "57664-050",
     "57664-051",
     "57664-052",
     "57664-083",
     "57664-084",
     "57664-085",
     "57664-086",
     "57664-087",
     "57664-088"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856",
     "1871456",
     "1871460",
     "1871462",
     "1871464",
     "1871466",
     "1871468"
    ],
    "spl_id": [
     "560b4c9e-9cce-4717-e063-6294a90a58c9"
    ],
    "spl_set_id": [
     "da3148af-f9b6-4725-adae-3595b4c7dc4b"
    ],
    "package_ndc": [
     "57664-047-88",
     "57664-046-88",
     "57664-048-88",
     "57664-049-88",
     "57664-050-88",
     "57664-051-88",
     "57664-052-88",
     "57664-083-88",
     "57664-084-88",
     "57664-085-88",
     "57664-086-88",
     "57664-087-88",
     "57664-088-88"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "47781-567-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214547"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Alvogen Inc."
    ],
    "product_ndc": [
     "47781-567",
     "47781-562",
     "47781-563",
     "47781-564",
     "47781-565",
     "47781-566",
     "47781-568"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "db02ec6b-f17f-ab22-b671-e1ddb90e017c"
    ],
    "spl_set_id": [
     "7f2dd6ee-3363-c87c-9693-ed838942556c"
    ],
    "package_ndc": [
     "47781-562-01",
     "47781-563-01",
     "47781-564-01",
     "47781-565-01",
     "47781-566-01",
     "47781-567-01",
     "47781-568-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01)",
   "company_name": "Alvogen",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2023",
   "package_ndc": "60505-4744-1",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-706-5575",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA216944"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-4744",
     "60505-4739",
     "60505-4740",
     "60505-4741",
     "60505-4742",
     "60505-4743",
     "60505-4745"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2eec36cd-6063-fea0-d6dd-b7a5c8df186b"
    ],
    "spl_set_id": [
     "ecad4442-a644-18e3-6ff2-fdbac45eec47"
    ],
    "package_ndc": [
     "60505-4739-1",
     "60505-4740-1",
     "60505-4741-1",
     "60505-4742-1",
     "60505-4743-1",
     "60505-4744-1",
     "60505-4745-1"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1)",
   "company_name": "Apotex Corp.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0527-4665-37",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215802"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "0527-4665",
     "0527-4661",
     "0527-4662",
     "0527-4663",
     "0527-4664",
     "0527-4666",
     "0527-4667"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "cb49954d-0f9d-4471-bc86-0c926473c00b"
    ],
    "spl_set_id": [
     "2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"
    ],
    "package_ndc": [
     "0527-4661-37",
     "0527-4662-37",
     "0527-4663-37",
     "0527-4664-37",
     "0527-4665-37",
     "0527-4666-37",
     "0527-4667-37"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "43547-607-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-931-9829",
   "availability": "Limited Availability",
   "related_info": "On allocation",
   "openfda": {
    "application_number": [
     "ANDA216266"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE CAPSULES"
    ],
    "manufacturer_name": [
     "Solco Healthcare US,LLC"
    ],
    "product_ndc": [
     "43547-607",
     "43547-602",
     "43547-603",
     "43547-604",
     "43547-605",
     "43547-606",
     "43547-608"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "d6435613-e052-4b4f-8bf7-4acb7458d8df"
    ],
    "spl_set_id": [
     "68b10d9f-ca3e-493d-a309-45f1d7e08061"
    ],
    "package_ndc": [
     "43547-602-10",
     "43547-603-10",
     "43547-604-10",
     "43547-605-10",
     "43547-606-10",
     "43547-607-10",
     "43547-608-10"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10)",
   "company_name": "Solco Healthcare US, LLC",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "64850-550-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-852-6657",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA218604"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Elite Laboratories, Inc."
    ],
    "product_ndc": [
     "64850-550",
     "64850-551",
     "64850-552",
     "64850-553",
     "64850-554",
     "64850-555",
     "64850-556"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2d33f701-8067-4a48-98cc-4e7dacaf3cc4"
    ],
    "spl_set_id": [
     "0e024b69-567c-4b40-9c3e-a2daec34256c"
    ],
    "package_ndc": [
     "64850-550-01",
     "64850-551-01",
     "64850-552-01",
     "64850-553-01",
     "64850-554-01",
     "64850-555-01",
     "64850-556-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)",
   "company_name": "Elite Laboratories, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "59417-101-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "877-TAKEDA-7 (1-877-825-3327)",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021977"
    ],
    "brand_name": [
     "VYVANSE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "59417-101",
     "59417-102",
     "59417-103",
     "59417-104",
     "59417-105",
     "59417-106",
     "59417-107",
     "59417-115",
     "59417-116",
     "59417-117",
     "59417-118",
     "59417-119",
     "59417-120"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854832",
     "854834",
     "854836",
     "854838",
     "854840",
     "854842",
     "854844",
     "854846",
     "854848",
     "854850",
     "854852",
     "1593856",
     "1593858",
     "1871456",
     "1871459",
     "1871460",
     "1871461",
     "1871462",
     "1871463",
     "1871464",
     "1871465",
     "1871466",
     "1871467",
     "1871468",
     "1871469"
    ],
    "spl_id": [
     "81d087b6-4cb4-466a-9693-679edeb062e2"
    ],
    "spl_set_id": [
     "704e4378-ca83-445c-8b45-3cfa51c1ecad"
    ],
    "package_ndc": [
     "59417-101-10",
     "59417-102-10",
     "59417-103-10",
     "59417-104-10",
     "59417-105-10",
     "59417-106-10",
     "59417-107-10",
     "59417-115-01",
     "59417-116-01",
     "59417-117-01",
     "59417-118-01",
     "59417-119-01",
     "59417-120-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Vyvanse, Capsule, 10 mg (NDC 59417-101-10)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "43547-608-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-931-9829",
   "availability": "Limited Availability",
   "related_info": "On allocation",
   "openfda": {
    "application_number": [
     "ANDA216266"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE CAPSULES"
    ],
    "manufacturer_name": [
     "Solco Healthcare US,LLC"
    ],
    "product_ndc": [
     "43547-608",
     "43547-602",
     "43547-603",
     "43547-604",
     "43547-605",
     "43547-606",
     "43547-607"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "d6435613-e052-4b4f-8bf7-4acb7458d8df"
    ],
    "spl_set_id": [
     "68b10d9f-ca3e-493d-a309-45f1d7e08061"
    ],
    "package_ndc": [
     "43547-602-10",
     "43547-603-10",
     "43547-604-10",
     "43547-605-10",
     "43547-606-10",
     "43547-607-10",
     "43547-608-10"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10)",
   "company_name": "Solco Healthcare US, LLC",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)",
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0480-3565-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "status": "Current",
   "dosage_form": "Capsule"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "57664-049-88",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-818-4555",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA214484"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Sun Pharmaceutical Industries, Inc."
    ],
    "product_ndc": [
     "57664-049",
     "57664-047",
     "57664-046",
     "57664-048",
     "57664-050",
     "57664-051",
     "57664-052",
     "57664-083",
     "57664-084",
     "57664-085",
     "57664-086",
     "57664-087",
     "57664-088"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856",
     "1871456",
     "1871460",
     "1871462",
     "1871464",
     "1871466",
     "1871468"
    ],
    "spl_id": [
     "560b4c9e-9cce-4717-e063-6294a90a58c9"
    ],
    "spl_set_id": [
     "da3148af-f9b6-4725-adae-3595b4c7dc4b"
    ],
    "package_ndc": [
     "57664-047-88",
     "57664-046-88",
     "57664-048-88",
     "57664-049-88",
     "57664-050-88",
     "57664-051-88",
     "57664-052-88",
     "57664-083-88",
     "57664-084-88",
     "57664-085-88",
     "57664-086-88",
     "57664-087-88",
     "57664-088-88"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0378-6856-77",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202835"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-6856",
     "0378-6854",
     "0378-6855",
     "0378-6857",
     "0378-6858",
     "0378-6859",
     "0378-6860"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "6e77cd71-95ae-4fa8-830b-ab62b714e4b9"
    ],
    "spl_set_id": [
     "efbde0f6-b848-4664-b741-c6c630e66108"
    ],
    "package_ndc": [
     "0378-6854-77",
     "0378-6855-77",
     "0378-6856-77",
     "0378-6857-77",
     "0378-6858-77",
     "0378-6859-77",
     "0378-6860-77"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0527-4663-37",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215802"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "0527-4663",
     "0527-4661",
     "0527-4662",
     "0527-4664",
     "0527-4665",
     "0527-4666",
     "0527-4667"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "cb49954d-0f9d-4471-bc86-0c926473c00b"
    ],
    "spl_set_id": [
     "2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"
    ],
    "package_ndc": [
     "0527-4661-37",
     "0527-4662-37",
     "0527-4663-37",
     "0527-4664-37",
     "0527-4665-37",
     "0527-4666-37",
     "0527-4667-37"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "09/20/2023",
   "package_ndc": "0527-4666-37",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215802"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "0527-4666",
     "0527-4661",
     "0527-4662",
     "0527-4663",
     "0527-4664",
     "0527-4665",
     "0527-4667"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "cb49954d-0f9d-4471-bc86-0c926473c00b"
    ],
    "spl_set_id": [
     "2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"
    ],
    "package_ndc": [
     "0527-4661-37",
     "0527-4662-37",
     "0527-4663-37",
     "0527-4664-37",
     "0527-4665-37",
     "0527-4666-37",
     "0527-4667-37"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "43547-605-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-931-9829",
   "availability": "Limited Availability",
   "related_info": "On allocation",
   "openfda": {
    "application_number": [
     "ANDA216266"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE CAPSULES"
    ],
    "manufacturer_name": [
     "Solco Healthcare US,LLC"
    ],
    "product_ndc": [
     "43547-605",
     "43547-602",
     "43547-603",
     "43547-604",
     "43547-606",
     "43547-607",
     "43547-608"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "d6435613-e052-4b4f-8bf7-4acb7458d8df"
    ],
    "spl_set_id": [
     "68b10d9f-ca3e-493d-a309-45f1d7e08061"
    ],
    "package_ndc": [
     "43547-602-10",
     "43547-603-10",
     "43547-604-10",
     "43547-605-10",
     "43547-606-10",
     "43547-607-10",
     "43547-608-10"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10)",
   "company_name": "Solco Healthcare US, LLC",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/01/2023",
   "package_ndc": "60505-4743-1",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-706-5575",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: Mid September 2026",
   "openfda": {
    "application_number": [
     "ANDA216944"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-4743",
     "60505-4739",
     "60505-4740",
     "60505-4741",
     "60505-4742",
     "60505-4744",
     "60505-4745"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2eec36cd-6063-fea0-d6dd-b7a5c8df186b"
    ],
    "spl_set_id": [
     "ecad4442-a644-18e3-6ff2-fdbac45eec47"
    ],
    "package_ndc": [
     "60505-4739-1",
     "60505-4740-1",
     "60505-4741-1",
     "60505-4742-1",
     "60505-4743-1",
     "60505-4744-1",
     "60505-4745-1"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)",
   "company_name": "Apotex Corp.",
   "shortage_reason": "Delay in shipping of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0406-5116-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-325-8888",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211840"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "SpecGx LLC"
    ],
    "product_ndc": [
     "0406-5116",
     "0406-5111",
     "0406-5112",
     "0406-5113",
     "0406-5114",
     "0406-5115",
     "0406-5117"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "b4be564a-404d-4ca1-bac0-ec9cf40fef93"
    ],
    "spl_set_id": [
     "806a1c15-0842-4787-b2ad-09a21fd96b37"
    ],
    "package_ndc": [
     "0406-5111-01",
     "0406-5112-01",
     "0406-5113-01",
     "0406-5114-01",
     "0406-5115-01",
     "0406-5116-01",
     "0406-5117-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01)",
   "company_name": "SpecGx LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0527-4667-37",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215802"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "0527-4667",
     "0527-4661",
     "0527-4662",
     "0527-4663",
     "0527-4664",
     "0527-4665",
     "0527-4666"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "cb49954d-0f9d-4471-bc86-0c926473c00b"
    ],
    "spl_set_id": [
     "2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"
    ],
    "package_ndc": [
     "0527-4661-37",
     "0527-4662-37",
     "0527-4663-37",
     "0527-4664-37",
     "0527-4665-37",
     "0527-4666-37",
     "0527-4667-37"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0406-5115-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-325-8888",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211840"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "SpecGx LLC"
    ],
    "product_ndc": [
     "0406-5115",
     "0406-5111",
     "0406-5112",
     "0406-5113",
     "0406-5114",
     "0406-5116",
     "0406-5117"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "b4be564a-404d-4ca1-bac0-ec9cf40fef93"
    ],
    "spl_set_id": [
     "806a1c15-0842-4787-b2ad-09a21fd96b37"
    ],
    "package_ndc": [
     "0406-5111-01",
     "0406-5112-01",
     "0406-5113-01",
     "0406-5114-01",
     "0406-5115-01",
     "0406-5116-01",
     "0406-5117-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01)",
   "company_name": "SpecGx LLC",
   "status": "Current"
  },
  {
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01)",
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0480-3569-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "status": "Current",
   "dosage_form": "Capsule"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/01/2023",
   "package_ndc": "60505-4742-1",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-706-5575",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: Late August 2026",
   "openfda": {
    "application_number": [
     "ANDA216944"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-4742",
     "60505-4739",
     "60505-4740",
     "60505-4741",
     "60505-4743",
     "60505-4744",
     "60505-4745"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2eec36cd-6063-fea0-d6dd-b7a5c8df186b"
    ],
    "spl_set_id": [
     "ecad4442-a644-18e3-6ff2-fdbac45eec47"
    ],
    "package_ndc": [
     "60505-4739-1",
     "60505-4740-1",
     "60505-4741-1",
     "60505-4742-1",
     "60505-4743-1",
     "60505-4744-1",
     "60505-4745-1"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1)",
   "company_name": "Apotex Corp.",
   "shortage_reason": "Delay in shipping of the drug",
   "status": "Current"
  },
  {
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01)",
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0480-3568-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "status": "Current",
   "dosage_form": "Capsule"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "64850-552-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-852-6657",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA218604"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Elite Laboratories, Inc."
    ],
    "product_ndc": [
     "64850-552",
     "64850-550",
     "64850-551",
     "64850-553",
     "64850-554",
     "64850-555",
     "64850-556"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2d33f701-8067-4a48-98cc-4e7dacaf3cc4"
    ],
    "spl_set_id": [
     "0e024b69-567c-4b40-9c3e-a2daec34256c"
    ],
    "package_ndc": [
     "64850-550-01",
     "64850-551-01",
     "64850-552-01",
     "64850-553-01",
     "64850-554-01",
     "64850-555-01",
     "64850-556-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)",
   "company_name": "Elite Laboratories, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0054-0374-25",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Available on allocation",
   "openfda": {
    "application_number": [
     "ANDA202827"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0054-0374",
     "0054-0660",
     "0054-0370",
     "0054-0371",
     "0054-0372",
     "0054-0373",
     "0054-0375"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"
    ],
    "spl_set_id": [
     "6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    ],
    "package_ndc": [
     "0054-0660-25",
     "0054-0370-25",
     "0054-0371-25",
     "0054-0372-25",
     "0054-0373-25",
     "0054-0374-25",
     "0054-0375-25"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0378-6855-77",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202835"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-6855",
     "0378-6854",
     "0378-6856",
     "0378-6857",
     "0378-6858",
     "0378-6859",
     "0378-6860"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "6e77cd71-95ae-4fa8-830b-ab62b714e4b9"
    ],
    "spl_set_id": [
     "efbde0f6-b848-4664-b741-c6c630e66108"
    ],
    "package_ndc": [
     "0378-6854-77",
     "0378-6855-77",
     "0378-6856-77",
     "0378-6857-77",
     "0378-6858-77",
     "0378-6859-77",
     "0378-6860-77"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0054-0373-25",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Available on allocation",
   "openfda": {
    "application_number": [
     "ANDA202827"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0054-0373",
     "0054-0660",
     "0054-0370",
     "0054-0371",
     "0054-0372",
     "0054-0374",
     "0054-0375"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"
    ],
    "spl_set_id": [
     "6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    ],
    "package_ndc": [
     "0054-0660-25",
     "0054-0370-25",
     "0054-0371-25",
     "0054-0372-25",
     "0054-0373-25",
     "0054-0374-25",
     "0054-0375-25"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "64850-553-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-852-6657",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA218604"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Elite Laboratories, Inc."
    ],
    "product_ndc": [
     "64850-553",
     "64850-550",
     "64850-551",
     "64850-552",
     "64850-554",
     "64850-555",
     "64850-556"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2d33f701-8067-4a48-98cc-4e7dacaf3cc4"
    ],
    "spl_set_id": [
     "0e024b69-567c-4b40-9c3e-a2daec34256c"
    ],
    "package_ndc": [
     "64850-550-01",
     "64850-551-01",
     "64850-552-01",
     "64850-553-01",
     "64850-554-01",
     "64850-555-01",
     "64850-556-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01)",
   "company_name": "Elite Laboratories, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "59417-105-10",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "877-TAKEDA-7 (1-877-825-3327)",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021977"
    ],
    "brand_name": [
     "VYVANSE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "59417-105",
     "59417-101",
     "59417-102",
     "59417-103",
     "59417-104",
     "59417-106",
     "59417-107",
     "59417-115",
     "59417-116",
     "59417-117",
     "59417-118",
     "59417-119",
     "59417-120"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854832",
     "854834",
     "854836",
     "854838",
     "854840",
     "854842",
     "854844",
     "854846",
     "854848",
     "854850",
     "854852",
     "1593856",
     "1593858",
     "1871456",
     "1871459",
     "1871460",
     "1871461",
     "1871462",
     "1871463",
     "1871464",
     "1871465",
     "1871466",
     "1871467",
     "1871468",
     "1871469"
    ],
    "spl_id": [
     "81d087b6-4cb4-466a-9693-679edeb062e2"
    ],
    "spl_set_id": [
     "704e4378-ca83-445c-8b45-3cfa51c1ecad"
    ],
    "package_ndc": [
     "59417-101-10",
     "59417-102-10",
     "59417-103-10",
     "59417-104-10",
     "59417-105-10",
     "59417-106-10",
     "59417-107-10",
     "59417-115-01",
     "59417-116-01",
     "59417-117-01",
     "59417-118-01",
     "59417-119-01",
     "59417-120-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Vyvanse, Capsule, 50 mg (NDC 59417-105-10)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "42858-166-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-827-0616",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215330"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Rhodes Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "42858-166",
     "42858-161",
     "42858-162",
     "42858-163",
     "42858-164",
     "42858-165",
     "42858-167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "0002e227-1109-4ecc-a8c5-4b4f11fac3cc"
    ],
    "spl_set_id": [
     "d918b40d-a461-41bc-b6c0-83dc76c28e32"
    ],
    "package_ndc": [
     "42858-161-01",
     "42858-162-01",
     "42858-163-01",
     "42858-164-01",
     "42858-165-01",
     "42858-166-01",
     "42858-167-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/24/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01)",
   "company_name": "Rhodes Pharmaceuticals L.P.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "42858-162-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-827-0616",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA215330"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Rhodes Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "42858-162",
     "42858-161",
     "42858-163",
     "42858-164",
     "42858-165",
     "42858-166",
     "42858-167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "0002e227-1109-4ecc-a8c5-4b4f11fac3cc"
    ],
    "spl_set_id": [
     "d918b40d-a461-41bc-b6c0-83dc76c28e32"
    ],
    "package_ndc": [
     "42858-161-01",
     "42858-162-01",
     "42858-163-01",
     "42858-164-01",
     "42858-165-01",
     "42858-166-01",
     "42858-167-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/24/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01)",
   "company_name": "Rhodes Pharmaceuticals L.P.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "57664-051-88",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-818-4555",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA214484"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Sun Pharmaceutical Industries, Inc."
    ],
    "product_ndc": [
     "57664-051",
     "57664-047",
     "57664-046",
     "57664-048",
     "57664-049",
     "57664-050",
     "57664-052",
     "57664-083",
     "57664-084",
     "57664-085",
     "57664-086",
     "57664-087",
     "57664-088"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856",
     "1871456",
     "1871460",
     "1871462",
     "1871464",
     "1871466",
     "1871468"
    ],
    "spl_id": [
     "560b4c9e-9cce-4717-e063-6294a90a58c9"
    ],
    "spl_set_id": [
     "da3148af-f9b6-4725-adae-3595b4c7dc4b"
    ],
    "package_ndc": [
     "57664-047-88",
     "57664-046-88",
     "57664-048-88",
     "57664-049-88",
     "57664-050-88",
     "57664-051-88",
     "57664-052-88",
     "57664-083-88",
     "57664-084-88",
     "57664-085-88",
     "57664-086-88",
     "57664-087-88",
     "57664-088-88"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "64850-554-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "888-852-6657",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA218604"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Elite Laboratories, Inc."
    ],
    "product_ndc": [
     "64850-554",
     "64850-550",
     "64850-551",
     "64850-552",
     "64850-553",
     "64850-555",
     "64850-556"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "2d33f701-8067-4a48-98cc-4e7dacaf3cc4"
    ],
    "spl_set_id": [
     "0e024b69-567c-4b40-9c3e-a2daec34256c"
    ],
    "package_ndc": [
     "64850-550-01",
     "64850-551-01",
     "64850-552-01",
     "64850-553-01",
     "64850-554-01",
     "64850-555-01",
     "64850-556-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01)",
   "company_name": "Elite Laboratories, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0054-0375-25",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Available on allocation",
   "openfda": {
    "application_number": [
     "ANDA202827"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0054-0375",
     "0054-0660",
     "0054-0370",
     "0054-0371",
     "0054-0372",
     "0054-0373",
     "0054-0374"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"
    ],
    "spl_set_id": [
     "6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    ],
    "package_ndc": [
     "0054-0660-25",
     "0054-0370-25",
     "0054-0371-25",
     "0054-0372-25",
     "0054-0373-25",
     "0054-0374-25",
     "0054-0375-25"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "65162-023-09",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202830"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "65162-023",
     "65162-024",
     "65162-025",
     "65162-026",
     "65162-027",
     "65162-028"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850"
    ],
    "spl_id": [
     "ba9f3370-3096-4d8c-9571-e28faf54291f"
    ],
    "spl_set_id": [
     "c11cb3b6-3dff-477b-a249-b4c3118edc5f"
    ],
    "package_ndc": [
     "65162-023-09",
     "65162-024-09",
     "65162-025-09",
     "65162-026-09",
     "65162-027-09",
     "65162-028-09"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "57664-050-88",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-818-4555",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA214484"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "Sun Pharmaceutical Industries, Inc."
    ],
    "product_ndc": [
     "57664-050",
     "57664-047",
     "57664-046",
     "57664-048",
     "57664-049",
     "57664-051",
     "57664-052",
     "57664-083",
     "57664-084",
     "57664-085",
     "57664-086",
     "57664-087",
     "57664-088"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856",
     "1871456",
     "1871460",
     "1871462",
     "1871464",
     "1871466",
     "1871468"
    ],
    "spl_id": [
     "560b4c9e-9cce-4717-e063-6294a90a58c9"
    ],
    "spl_set_id": [
     "da3148af-f9b6-4725-adae-3595b4c7dc4b"
    ],
    "package_ndc": [
     "57664-047-88",
     "57664-046-88",
     "57664-048-88",
     "57664-049-88",
     "57664-050-88",
     "57664-051-88",
     "57664-052-88",
     "57664-083-88",
     "57664-084-88",
     "57664-085-88",
     "57664-086-88",
     "57664-087-88",
     "57664-088-88"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/14/2023",
   "package_ndc": "0406-5117-01",
   "generic_name": "Lisdexamfetamine Dimesylate Capsule",
   "contact_info": "800-325-8888",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211840"
    ],
    "brand_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "generic_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "manufacturer_name": [
     "SpecGx LLC"
    ],
    "product_ndc": [
     "0406-5117",
     "0406-5111",
     "0406-5112",
     "0406-5113",
     "0406-5114",
     "0406-5115",
     "0406-5116"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LISDEXAMFETAMINE DIMESYLATE"
    ],
    "rxcui": [
     "854830",
     "854834",
     "854838",
     "854842",
     "854846",
     "854850",
     "1593856"
    ],
    "spl_id": [
     "b4be564a-404d-4ca1-bac0-ec9cf40fef93"
    ],
    "spl_set_id": [
     "806a1c15-0842-4787-b2ad-09a21fd96b37"
    ],
    "package_ndc": [
     "0406-5111-01",
     "0406-5112-01",
     "0406-5113-01",
     "0406-5114-01",
     "0406-5115-01",
     "0406-5116-01",
     "0406-5117-01"
    ],
    "unii": [
     "SJT761GEGS"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Capsule",
   "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01)",
   "company_name": "SpecGx LLC",
   "status": "Current"
  }
 ]
}